与威尔逊同行 一份由患者主导的项目

← 返回所有答案

Could uncontrolled Wilson disease cause a miscarriage — and will treatment help next time?

Yes — untreated or poorly controlled Wilson disease is linked to higher miscarriage rates, and evidence shows that staying on anti-copper treatment significantly improves pregnancy outcomes.

Losing a pregnancy is devastating, and if you have Wilson disease it is natural to ask whether the two are connected. The honest answer is: quite possibly, yes. Uncontrolled Wilson disease — meaning copper accumulation that hasn’t been brought under management — is associated with a meaningfully higher rate of miscarriage compared with treated patients. The good news is that the evidence also shows treatment makes a real difference to your next pregnancy.

What the research shows about Wilson disease and miscarriage

The most informative study to date is a large multicenter analysis by Pfeiffenberger and colleagues, published in Hepatology in 2018, which followed 282 pregnancies in 136 women with Wilson disease across multiple specialist centres.1 Their key finding on miscarriage was stark:

  • In untreated women, the spontaneous abortion rate was significantly higher than in the general population.
  • In treated women — those continuing anti-copper therapy through pregnancy — outcomes were substantially better, with miscarriage rates approaching those seen in the general population.

A 2024 review in Clinical Liver Disease confirmed this picture: ongoing copper accumulation during an untreated pregnancy creates a hostile environment for fetal development, while maintained treatment appears to be both safe for the fetus and protective for the pregnancy.2

Why does excess copper matter here? Copper is a potent oxidant at high concentrations. In Wilson disease the liver cannot excrete it normally, and copper accumulates not only in the liver but eventually in other tissues.3 During pregnancy, the liver’s metabolic demands increase substantially. In an untreated patient, this can tip an already-stressed liver further toward dysfunction. Elevated circulating copper can also directly affect the placenta and developing embryo, though the exact mechanisms in human pregnancy are still being studied.1

Did Wilson disease definitely cause your miscarriage?

Probably not in isolation, and you should not assume it did without speaking to your specialist. Miscarriage is common — roughly 10–20% of known pregnancies end this way in the general population — and most are caused by chromosomal abnormalities in the embryo that have nothing to do with Wilson disease.4 Your doctor may recommend testing the products of conception (if available) to check for chromosomal causes, and a general fertility workup if you’ve had two or more losses.

What Wilson disease can do is add to the risk on top of whatever other factors may be present. So if your copper was not well controlled, that is a plausible contributor — even if it isn’t the only explanation.

One important question to ask your specialist: at the time of the pregnancy, how controlled was your Wilson disease? If you had already achieved stable copper balance on treatment, that is a different situation than if you had untreated or recently diagnosed disease. Your 24-hour urine copper levels and ceruloplasmin values around the time of the pregnancy (if available) are the numbers your care team will want to see.3

What changes for your next pregnancy

If your Wilson disease was not under control, the single most important step is achieving and maintaining copper balance before conceiving again. Guidelines from both the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) strongly recommend that Wilson disease be well-controlled for a period — typically at minimum 6–12 months — before a planned pregnancy, with treatment continued throughout.53

Do not stop your medication when you find out you are pregnant. This is one of the most important messages from the specialist literature. The risk of stopping treatment abruptly — which can trigger acute liver failure — is far greater than any risk from continuing carefully monitored chelation therapy or zinc. The Pfeiffenberger study found that women who continued treatment had significantly better outcomes; those who stopped had worse ones.1

Which medication is safest in pregnancy? This is a detailed conversation for your hepatologist, and the answer depends on what you’re currently taking:

  • Zinc is widely used in pregnancy and has a strong safety record in Wilson disease.2
  • Trientine and D-penicillamine are generally continued in the lowest effective dose — stopping them is riskier than continuing.5
  • Dose adjustments may be made because pregnancy changes how the body handles these medications; your team will monitor accordingly.

See the pregnancy post for a fuller overview of medication decisions during pregnancy. The present article focuses on the specific question of miscarriage and what comes next.

Monitoring during a future pregnancy

If you’ve had a prior pregnancy loss, your care team will likely want closer monitoring next time. What that typically involves:12

  • Regular liver function tests — every trimester at minimum, more often if there is concern.
  • 24-hour urine copper at the start of each trimester to track copper excretion and medication adequacy.
  • Coordination between your hepatologist (or metabolic specialist) and your obstetrician from early in the pregnancy.
  • Discussion with a maternal-fetal medicine specialist if you have significant liver disease or a complicated history.

Your baby does not need to be screened for Wilson disease at birth — newborns are not tested this way. Post-delivery screening for your child can happen in childhood; the family-screening article explains when and how that typically works.

What to tell your doctor

At your next appointment, specifically ask:

  1. Was my copper adequately controlled during the last pregnancy? What do my labs from that period show?
  2. What is my copper status now, and what would an acceptable pre-conception window look like?
  3. Do I need to adjust my current treatment before trying again?
  4. Should I see a maternal-fetal medicine specialist before conceiving?

The what-to-tell-doctor post has a template for preparing these conversations.

A word on hope

It is worth knowing that the large majority of women with Wilson disease who are well-treated go on to have successful pregnancies. In the Pfeiffenberger cohort, treated patients had live-birth rates that were comparable with the general population.1 A miscarriage is a loss, and it deserves space and grief — but it does not mean future pregnancies are out of reach. With proper preparation and monitoring, the evidence is genuinely encouraging.

This article is patient education, not medical advice. Pregnancy planning with Wilson disease should be managed with your hepatologist, obstetrician, and — where available — a maternal-fetal medicine specialist. Do not change or stop any medication without specialist guidance.

References


  1. Pfeiffenberger, Jan, Sandra Beinhardt, Daniel N. Gotthardt, et al. “Pregnancy in Wilson’s disease: Management and outcome.” Hepatology 67, no. 4 (2018): 1261–1269. https://doi.org/10.1002/hep.29490. 

  2. Weinstein, David, and Dhiren A. Shah. “Wilson disease and pregnancy.” Clinical Liver Disease 23, no. 1 (2024). https://doi.org/10.1097/cld.0000000000000110. 

  3. Czlonkowska, Anna, Tomasz Litwin, Piotr Chabik, et al. “Wilson disease.” Nature Reviews Disease Primers 4, no. 1 (2018): article 22. https://doi.org/10.1038/s41572-018-0024-5. 

  4. European Association for the Study of the Liver. “EASL Clinical Practice Guidelines: Wilson’s disease.” Journal of Hepatology 56, no. 3 (2012): 671–685. https://doi.org/10.1016/j.jhep.2011.11.007. 

  5. Schilsky, Michael L., Eve A. Roberts, Jeff M. Bronstein, et al. “A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases.” Hepatology 82, no. 3 (2025): E41–E90. https://doi.org/10.1002/hep.32801. 

  6. Reuner, Ulrike, and Juergen Dinger. “Pregnancy and Wilson disease: management and outcome of mother and newborns—experiences of a perinatal centre.” Annals of Translational Medicine 7, suppl. S2 (2019): S56. https://doi.org/10.21037/atm.2019.04.40. 

  7. Alkhouri, Naim, Regino P. Gonzalez-Peralta, and Valentina Medici. “Wilson disease: a summary of the updated AASLD Practice Guidance.” Hepatology Communications 7, no. 6 (2023). https://doi.org/10.1097/HC9.0000000000000150. 

本文是患者教育内容,不能替代医学建议。请始终就你的诊疗决策与你自己的医生团队沟通。